Stay updated with breaking news from Nasdaq Alt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Altimmune, Inc. (NASDAQ:ALT – Get Free Report) traded down 4.2% on Tuesday . The stock traded as low as $10.89 and last traded at $10.91. 437,142 shares traded hands during trading, a decline of 95% from the average session volume of 7,999,974 shares. The stock had previously closed at $11.39. Wall Street Analyst […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report)’s share price was down 5.2% during mid-day trading on Friday . The stock traded as low as $10.67 and last traded at $11.02. Approximately 4,740,645 shares traded hands during mid-day trading, an increase of 35% from the average daily volume of 3,512,153 shares. The stock had previously closed […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) shares saw an uptick in trading volume on Wednesday . 2,945,008 shares were traded during mid-day trading, a decline of 14% from the previous session’s volume of 3,413,630 shares.The stock last traded at $11.87 and had previously closed at $10.97. Analyst Upgrades and Downgrades A number of brokerages […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) saw unusually large options trading on Tuesday. Traders bought 7,433 call options on the company. This is an increase of approximately 54% compared to the average daily volume of 4,842 call options. Altimmune Stock Performance Shares of ALT stock traded up $0.87 on Tuesday, hitting $10.14. The company […]
GAITHERSBURG, Md., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that...